Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions
Psychosis Manifestation in Patients with SLE
Arthritis Rheumatol; ePub 2018 Oct 30; Hanly, et al
Psychosis is an infrequent manifestation of neuropsychiatric (NP) events in persons with systemic lupus erythematosus (SLE), according to a recent study. Generally, it occurs early after SLE onset and has a significant negative impact on health status. Patients were evaluated annually for 19 NP events including psychosis. SLE disease activity 2000, Systemic Lupus International Collaborating Clinics/American College of Rheumatology (SLICC/ACR) damage index, and 36-Item Short Form Health Survey (SF‐36) scores were collected. Researchers found:
- Of 1,826 SLE patients, 88.8% were female, 48.8% Caucasian; mean±SD age was 35.1±13.3 years, disease duration 5.6±4.2 months and follow‐up 7.4±4.5 years.
- There were 31 psychotic events in 28/1,826 (1.53%) patients and most (26/28; 93%) had a single event.
- In the majority of patients (20/25; 80%) and events (28/31; 90%), psychosis was attributed to SLE, usually within 3 years of SLE diagnosis.
- Positive associations with lupus psychosis were prior SLE NP events, male sex, younger age at SLE diagnosis (per 10 years younger), and African ancestry.
- By physician assessment most psychotic events resolved by the second annual visit following onset, in parallel with an improvement in patient reported SF‐36 summary and subscale scores.
Hanly JG, Li Q, Su L, et al. Psychosis in systemic lupus erythematosus. [Published online ahead of print October 30, 2018]. Arthritis Rheumatol. doi:10.1002/art.40764.